CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery

Abadi, 2017, A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action, PLoS Comput Biol, 13, e1005807, 10.1371/journal.pcbi.1005807 Abu-Remaileh, 2018, WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia, Cell Death Dis, 9, 511, 10.1038/s41419-018-0510-4 Abutaleb, 2020, Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention, Gastroenterol Clin North Am, 49, 191, 10.1016/j.gtc.2020.01.002 Adamson, 2016, A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response, Cell, 167, 1867, 10.1016/j.cell.2016.11.048 Aevermann, 2021, A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing, Genome Res, 31, 1767, 10.1101/gr.275569.121 Akula, 2019, RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma, Expert Opin Ther Targets, 23, 915, 10.1080/14728222.2019.1685501 Amaddeo, 2021, Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area, JHEP Rep, 3 Anderson, 2020, The tumor microenvironment, Curr Biol, 30, R921, 10.1016/j.cub.2020.06.081 Antoniou, 2021, Base and Prime Editing Technologies for Blood Disorders, Frontiers in Genome Editing, 3, 10.3389/fgeed.2021.618406 Ardelt, 2019, Inhibition of Cyclin-Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy, Hepatology, 69, 376, 10.1002/hep.30190 Arnan, 2022, Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages, BMC Genomics, 23, 402, 10.1186/s12864-022-08612-7 Bae, 2014, Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases, Bioinformatics, 30, 1473, 10.1093/bioinformatics/btu048 Balak, 2019, Highly efficient ex vivo lentiviral transduction of primary human pancreatic exocrine cells, Scientific Reports, 9, 15870, 10.1038/s41598-019-51763-z Bao, 2021, Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer, Cell Rep, 34, 10.1016/j.celrep.2020.108676 Batır, 2019, Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3, Mol Biol Rep, 46, 6471, 10.1007/s11033-019-05093-y Behler, 2020, Approaches to study CRISPR RNA biogenesis and the key players involved, Methods, 172, 12, 10.1016/j.ymeth.2019.07.015 Bjursell, 2018, Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype, EBioMedicine, 29, 104, 10.1016/j.ebiom.2018.02.015 Brunello, 2022, Genome-scale single-cell CRISPR screens, Nature Reviews Genetics, 23, 459, 10.1038/s41576-022-00517-1 Bult, 2019, Mouse Genome Database (MGD) 2019, Nucleic Acids Res, 47, D801, 10.1093/nar/gky1056 Butiuc-Keul, 2022, CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes, Microb Physiol, 32, 2, 10.1159/000516643 Cantsilieris, 2017, Targeted Capture and High-Throughput Sequencing Using Molecular Inversion Probes (MIPs), Methods Mol Biol, 1492, 95, 10.1007/978-1-4939-6442-0_6 Carter, 2015, Chapter 11 - Gene Delivery Strategies, 239 Caruso, 2019, Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response, Gastroenterology, 157, 760, 10.1053/j.gastro.2019.05.001 Chand, 2022, Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis, Oncogene, 41, 3778, 10.1038/s41388-022-02394-8 Chen, 2018, Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer, Clin Cancer Res, 24, 1176, 10.1158/1078-0432.CCR-17-2066 Chen, 2019, CRISPR-Cas9 for cancer therapy: Opportunities and challenges, Cancer Lett, 447, 48, 10.1016/j.canlet.2019.01.017 Chen, 2020, CRISPR system: Discovery, development and off-target detection, Cell Signal, 70, 10.1016/j.cellsig.2020.109577 Chen, 2021, CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer, Cancer Commun (Lond), 41, 121, 10.1002/cac2.12125 Chen, 2022, CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway, Sci China Life Sci, 65, 1998, 10.1007/s11427-021-2067-7 Chen, 2022, CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma, Mol Cancer, 21, 11, 10.1186/s12943-021-01466-9 Cheng, 2022, High fructose diet: A risk factor for immune system dysregulation, Human Immunology, 83, 538, 10.1016/j.humimm.2022.03.007 Cheung, 2018, Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9, Lab Invest, 98, 968, 10.1038/s41374-018-0056-1 Choi, 2019, CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma, J Immunother Cancer, 7, 304, 10.1186/s40425-019-0806-7 Chow, 2017, AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma, Nat Neurosci, 20, 1329, 10.1038/nn.4620 Chow, 2018, Cancer CRISPR Screens In Vivo, Trends Cancer, 4, 349, 10.1016/j.trecan.2018.03.002 Coelho, M.A., et al., Base editing screens map mutations affecting IFNγ signalling in cancer. bioRxiv, 2022: p. 2022.03.29.486051. Conant, 2022, Inference of CRISPR Edits from Sanger Trace Data, The CRISPR Journal, 5, 123, 10.1089/crispr.2021.0113 Concordet, 2018, CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens, Nucleic Acids Research, 46, W242, 10.1093/nar/gky354 Coriat, 2012, Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo, Mol Cancer Ther, 11, 2284, 10.1158/1535-7163.MCT-12-0093 Craig, 2020, Tumour evolution in hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 17, 139, 10.1038/s41575-019-0229-4 C.J. Creighton Making Use of Cancer Genomic Databases Curr Protoc Mol Biol 121 2018 p. 19.14.1-19.14.13. Cucarull, 2021, Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species, Antioxidants (Basel), 10 Cuella-Martin, 2021, Functional interrogation of DNA damage response variants with base editing screens, Cell, 184, 1081, 10.1016/j.cell.2021.01.041 Dai, 2021, In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy, Nature Communications, 12, 3055, 10.1038/s41467-021-23316-4 Datlinger, 2017, Pooled CRISPR screening with single-cell transcriptome readout, Nat Methods, 14, 297, 10.1038/nmeth.4177 DeWeirdt, 2020, Genetic screens in isogenic mammalian cell lines without single cell cloning, Nat Commun, 11, 752, 10.1038/s41467-020-14620-6 DeWeirdt, 2021, Optimization of AsCas12a for combinatorial genetic screens in human cells, Nat Biotechnol, 39, 94, 10.1038/s41587-020-0600-6 Dixit, 2016, Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens, Cell, 167, 1853, 10.1016/j.cell.2016.11.038 Doench, 2014, Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation, Nature Biotechnology, 32, 1262, 10.1038/nbt.3026 Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat Biotechnol, 34, 184, 10.1038/nbt.3437 D'Souza, 2020, Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma, World J Gastroenterol, 26, 5759, 10.3748/wjg.v26.i38.5759 Dubrot, 2021, <em>Invivo</em> screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma, Immunity, 54, 571, 10.1016/j.immuni.2021.01.001 Elegheert, 2018, Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins, Nature Protocols, 13, 2991, 10.1038/s41596-018-0075-9 El-Khoueiry, 2021, Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040, Journal of Clinical Oncology, 39, 269, 10.1200/JCO.2021.39.3_suppl.269 Emes, 2003, Comparison of the genomes of human and mouse lays the foundation of genome zoology, Human Molecular Genetics, 12, 701, 10.1093/hmg/ddg078 Firth, 2015, Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs, Cell Rep, 12, 1385, 10.1016/j.celrep.2015.07.062 Freeman, 2019, Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion, Cell Rep, 28, 2784, 10.1016/j.celrep.2019.08.017 Gao, 2017, FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib, J Exp Clin Cancer Res, 36, 8, 10.1186/s13046-016-0478-9 Ge, 2021, Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients, Clin Res Hepatol Gastroenterol, 45, 10.1016/j.clinre.2020.11.004 Gonçalves, 2021, Minimal genome-wide human CRISPR-Cas9 library, Genome Biol, 22, 40, 10.1186/s13059-021-02268-4 Gonzalez-Sanchez, 2021, The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?, Cancers (Basel), 13, 10.3390/cancers13133248 Greener, 2022, A guide to machine learning for biologists, Nature Reviews Molecular Cell Biology, 23, 40, 10.1038/s41580-021-00407-0 Grunblatt, 2020, MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity, Genes Dev, 34, 1210, 10.1101/gad.340133.120 Gu, 2021, Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade, Cancer Discov, 11, 1524, 10.1158/2159-8290.CD-20-0812 Guo, 2021, Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer, Genome Med, 13, 166, 10.1186/s13073-021-00981-0 Gupta, 2019, CRISPR-Cas9 system: A new-fangled dawn in gene editing, Life Sci, 232, 10.1016/j.lfs.2019.116636 György, 2019, Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss, Nat Med, 25, 1123, 10.1038/s41591-019-0500-9 Hahn, 2019, CRISPR/Cas precision: do we need to worry about off-targeting in plants?, Plant Cell Reports, 38, 437, 10.1007/s00299-018-2355-9 Hanna, 2021, Massively parallel assessment of human variants with base editor screens, Cell, 184, 1064, 10.1016/j.cell.2021.01.012 Hart, 2015, High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities, Cell, 163, 1515, 10.1016/j.cell.2015.11.015 He, 2020, WNT/β-catenin signaling in the development of liver cancers, Biomed Pharmacother, 132, 10.1016/j.biopha.2020.110851 Heigwer, 2014, E-CRISP: fast CRISPR target site identification, Nature Methods, 11, 122, 10.1038/nmeth.2812 Henriksson, 2019, Genome-wide CRISPR Screens in T Helper Cells Reveal Pervasive Crosstalk between Activation and Differentiation, Cell, 176, 882, 10.1016/j.cell.2018.11.044 Hiranniramol, 2020, Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency, Bioinformatics, 36, 2684, 10.1093/bioinformatics/btaa041 Hoffmann, 2011, Functional analysis of bispecific antibody (EpCAMxCD3)-mediated T-lymphocyte and cancer cell interaction by single-cell force spectroscopy, Int J Cancer, 128, 2096, 10.1002/ijc.25556 Hou, 2015, Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection, Sci Rep, 5, 15577, 10.1038/srep15577 Hou, 2017, A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220, Cancer Res, 77, 4402, 10.1158/0008-5472.CAN-16-1627 Hsu, 2017, Aryl hydrocarbon receptor promotes hepatocellular carcinoma tumorigenesis by targeting intestine-specific homeobox expression, Mol Carcinog, 56, 2167, 10.1002/mc.22658 Huang, 2021, Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction, Genome Biology, 22, 80, 10.1186/s13059-021-02305-2 Huang, 2022, Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma, Int J Biol Sci, 18, 4357, 10.7150/ijbs.69969 Hyrina, 2019, A Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for Hepatitis B Surface Antigen Production, Cell Rep, 29, 2970, 10.1016/j.celrep.2019.10.113 Iwagami, 2016, Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma, Hepatology, 63, 1213, 10.1002/hep.28411 Jaitin, 2016, Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq, Cell, 167, 1883, 10.1016/j.cell.2016.11.039 Janik, 2020, Various Aspects of a Gene Editing System-CRISPR-Cas9, Int J Mol Sci, 21, 10.3390/ijms21249604 Ji, 2015, Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression, BMC Cancer, 15, 801, 10.1186/s12885-015-1798-4 Ji, 2022, In vivo multidimensional CRISPR screens identify <i>Lgals2</i> as an immunotherapy target in triple-negative breast cancer. Science, Advances, 8 Jiang, H., et al., Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proceedings of the National Academy of Sciences, 2020. 117(9): p. 4770-4780. Jin, 2020, In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes, Science, 370, 10.1126/science.aaz6063 Jin, 2021, EGFR activation limits the response of liver cancer to lenvatinib, Nature, 595, 730, 10.1038/s41586-021-03741-7 Jung, 2018, CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells, Cancer Res, 78, 4692, 10.1158/0008-5472.CAN-18-0030 Kang, 2015, B7–H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway, Cancer Cell International, 15, 45, 10.1186/s12935-015-0195-z Kaur, 2019, Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer, Scientific Reports, 9, 1482, 10.1038/s41598-018-37574-8 Kawamoto, 2020, Identification of Characteristic Genomic Markers in Human Hepatoma HuH-7 and Huh7.5.1-8 Cell Lines, Front Genet, 11, 10.3389/fgene.2020.546106 Kazemian, 2022, Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components, Molecular Pharmaceutics, 19, 1669, 10.1021/acs.molpharmaceut.1c00916 Kazimierska, M., et al., CRISPR/Cas9 screen for functional MYC binding sites reveals MYC-dependent vulnerabilities in K562 cells. bioRxiv, 2021: p. 2021.08.02.454734. Keys, 2022, Genome-scale CRISPR screening in a single mouse liver, Cell Genom, 2 Kieckhaefer, 2019, Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9, Semin Liver Dis, 39, 261, 10.1055/s-0039-1678725 Kim, 2004, Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas, Eur J Cancer, 40, 136, 10.1016/S0959-8049(03)00659-2 Kim, 2018, Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis, Hepatology, 67, 2287, 10.1002/hep.29738 Kim, 2021, Genome editing of immune cells using CRISPR/Cas9, BMB Rep, 54, 59, 10.5483/BMBRep.2021.54.1.245 Kim, 2021, Single-cell characterization of CRISPR-modified transcript isoforms with nanopore sequencing, Genome Biology, 22, 331, 10.1186/s13059-021-02554-1 Kodama, 2017, In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer, Proc Natl Acad Sci U S A, 114, E7301, 10.1073/pnas.1705441114 Kontos, 2021, B7–H3: An Attractive Target for Antibody-based Immunotherapy, Clin Cancer Res, 27, 1227, 10.1158/1078-0432.CCR-20-2584 Kudo, 2018, Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial, The Lancet (British edition), 391, 1163 Kuhn, 2021, Moving from in vitro to in vivo CRISPR screens, Gene and Genome Editing, 2, 10.1016/j.ggedit.2021.100008 Kulsuptrakul, 2021, A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection, Cell Rep, 34, 10.1016/j.celrep.2021.108859 Kwan, 2020, Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes, Hepatology, 71, 275, 10.1002/hep.30807 Kweon, 2020, A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants, Oncogene, 39, 30, 10.1038/s41388-019-0968-2 Labuhn, 2018, Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications, Nucleic Acids Res, 46, 1375, 10.1093/nar/gkx1268 Labun, 2019, CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing, Nucleic Acids Research, 47, W171, 10.1093/nar/gkz365 Lakkis, 2022, A multi-use deep learning method for CITE-seq and single-cell RNA-seq data integration with cell surface protein prediction and imputation, Nature Machine Intelligence, 4, 940, 10.1038/s42256-022-00545-w Lawson, 2020, Functional genomic landscape of cancer-intrinsic evasion of killing by T cells, Nature, 586, 120, 10.1038/s41586-020-2746-2 Le, 2021, Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer, Cancers (Basel), 13, 10.3390/cancers13061372 Lee, 2020, Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study, Lancet Oncol, 21, 808, 10.1016/S1470-2045(20)30156-X Li, 2018, Genome-wide CRISPR-KO Screen Uncovers mTORC1-Mediated Gsk3 Regulation in Naive Pluripotency Maintenance and Dissolution, Cell Rep, 24, 489, 10.1016/j.celrep.2018.06.027 Li, 2020, Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer, Cancer Res, 80, 3556, 10.1158/0008-5472.CAN-19-3782 Li, 2020, In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma, Cancer Discovery, 10, 270, 10.1158/2159-8290.CD-19-0780 Li, 2021, MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis, Cancer Lett, 519, 161, 10.1016/j.canlet.2021.07.029 Li, 2022, A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq data, Bioinformatics, 38, 4885, 10.1093/bioinformatics/btac617 Li, 2022, Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer, Theranostics, 12, 3818, 10.7150/thno.71833 Liang, 2020, Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition, Cancer Res, 80, 510, 10.1158/0008-5472.CAN-18-3374 Liang, 2021, TRIM26 is a critical host factor for HCV replication and contributes to host tropism, Sci Adv, 7, 10.1126/sciadv.abd9732 Lin, 2014, Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations, Nat Commun, 5, 4767, 10.1038/ncomms5767 Lin, 2020, Study on the hepatocellular carcinoma model with metastasis, Genes Dis, 7, 336, 10.1016/j.gendis.2019.12.008 Listgarten, 2018, Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs, Nature Biomedical Engineering, 2, 38, 10.1038/s41551-017-0178-6 Liu, 2017, Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection, Cell Biosci, 7, 47, 10.1186/s13578-017-0174-2 Liu, 2018, Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites, Nature Biotechnology, 36, 1203, 10.1038/nbt.4283 Liu, 2019, Pooled library screening with multiplexed Cpf1 library, Nat Commun, 10, 3144, 10.1038/s41467-019-10963-x Liu, 2021, Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects, Frontiers in Immunology, 12 Liu, 2021, Machine Intelligence in Single-Cell Data Analysis: Advances and New Challenges, Frontiers in Genetics, 12 Liu, 2022, Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors, Scientific Reports, 12, 5924, 10.1038/s41598-022-09889-0 Liu, 2022, Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma, Front Genet, 13 Liu, 2022, Base editor enables rational genome-scale functional screening for enhanced industrial phenotypes in <i>Corynebacterium glutamicum</i>. Science, Advances, 8 Llovet, 2021, Hepatocellular carcinoma. Nature Reviews Disease Primers, 7, 6, 10.1038/s41572-020-00240-3 Llovet, 2022, Immunotherapies for hepatocellular carcinoma, Nature Reviews Clinical Oncology, 19, 151, 10.1038/s41571-021-00573-2 Lo, 2017, Genetic and epigenetic control of gene expression by CRISPR-Cas systems, F1000Res, 6 Loesch, 2019, Potentials of CRISPR in liver research and therapy, Clinics and Research in Hepatology and Gastroenterology, 43, 5, 10.1016/j.clinre.2018.05.001 Lu, 2021, Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance, Cell Death Discov, 7, 359, 10.1038/s41420-021-00747-y Luo, 2018, Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway, Phytother Res, 32, 2009, 10.1002/ptr.6132 Ma, 2015, A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death, Cell Rep, 12, 673, 10.1016/j.celrep.2015.06.049 Mair, 2019, Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies, Cell Rep, 27, 599, 10.1016/j.celrep.2019.02.041 Malaguarnera, 2000, Increase of serum beta2-microglobulin in patients affected by HCV correlated hepatocellular carcinoma, Eur J Gastroenterol Hepatol, 12, 937, 10.1097/00042737-200012080-00014 Manguso, 2017, In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target, Nature, 547, 413, 10.1038/nature23270 McKenna, 2018, FlashFry: a fast and flexible tool for large-scale CRISPR target design, BMC Biology, 16, 74, 10.1186/s12915-018-0545-0 Mehta, 2021, Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic, Clin Gastroenterol Hepatol, 19, 1520, 10.1016/j.cgh.2020.06.072 Meier, 2017, GUIDES: sgRNA design for loss-of-function screens, Nat Methods, 14, 831, 10.1038/nmeth.4423 Mendes de Almeida, 2019, Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 system, Annals of Medicine, 51, 40, 10.1080/07853890.2018.1561848 Meroni, 2020, Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes, EBioMedicine, 52, 10.1016/j.ebiom.2020.102658 Michlits, 2020, Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles, Nature Methods, 17, 708, 10.1038/s41592-020-0850-8 Miller, 2017, Transcription elongation factors represent in vivo cancer dependencies in glioblastoma, Nature, 547, 355, 10.1038/nature23000 Minciuna, 2022, Is Fasting Good When One Is at Risk of Liver Cancer?, Cancers, 14, 10.3390/cancers14205084 Mintz, 2020, CRISPR/Cas9-mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1-mutated breast cancer cells, Bioeng Transl Med, 5, e10152, 10.1002/btm2.10152 Modrzejewski, 2020, Which Factors Affect the Occurrence of Off-Target Effects Caused by the Use of CRISPR/Cas: A Systematic Review in Plants, Front Plant Sci, 11, 10.3389/fpls.2020.574959 Monaco, 2015, A comparison of human and mouse gene co-expression networks reveals conservation and divergence at the tissue, pathway and disease levels, BMC Evol Biol, 15, 259, 10.1186/s12862-015-0534-7 Monteys, 2017, CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo, Mol Ther, 25, 12, 10.1016/j.ymthe.2016.11.010 Moreno-Mateos, 2015, CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo, Nature Methods, 12, 982, 10.1038/nmeth.3543 Muranen, 2017, Starved epithelial cells uptake extracellular matrix for survival, Nature Communications, 8, 13989, 10.1038/ncomms13989 Naito, 2015, CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites, Bioinformatics, 31, 1120, 10.1093/bioinformatics/btu743 Newman, R. and P. Tolar, Genome-wide screens identify calcium signaling as a key regulator of IgE&lt;sup&gt;+&lt;/sup&gt; plasma cell differentiation and survival. bioRxiv, 2021: p. 2021.03.02.433398. Nie, 2021, Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma, J Control Release, 333, 362, 10.1016/j.jconrel.2021.03.030 Nurk, 2022, The complete sequence of a human genome, Science, 376, 44, 10.1126/science.abj6987 Nwosu, 2018, Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours, Journal of Experimental & Clinical Cancer Research, 37, 211, 10.1186/s13046-018-0872-6 O'Donnell, 2010, The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor, PLoS One, 5, 10.1371/journal.pone.0013128 Pan, 2022, Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma, Autophagy, 1 Park, 2017, A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors, Nat Genet, 49, 193, 10.1038/ng.3741 Park, 2015, Cas-Designer: a web-based tool for choice of CRISPR-Cas9 target sites, Bioinformatics, 31, 4014, 10.1093/bioinformatics/btv537 Patel, 2015, Diagnostic delays are common among patients with hepatocellular carcinoma, J Natl Compr Canc Netw, 13, 543, 10.6004/jnccn.2015.0074 Patra, 2014, The pentose phosphate pathway and cancer, Trends Biochem Sci, 39, 347, 10.1016/j.tibs.2014.06.005 Peets, 2019, Minimized double guide RNA libraries enable scale-limited CRISPR/Cas9 screens, bioRxiv Perez, 2017, GuideScan software for improved single and paired CRISPR guide RNA design, Nat Biotechnol, 35, 347, 10.1038/nbt.3804 Perumal, 2019, PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells, Lung Cancer, 130, 25, 10.1016/j.lungcan.2019.01.013 Pettitt, 2018, Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance, Nat Commun, 9, 1849, 10.1038/s41467-018-03917-2 Pierce, 2021, High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer, Nature Communications, 12, 2969, 10.1038/s41467-021-23213-w Pliatsika, 2015, “Off-Spotter”: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs, Biology Direct, 10, 4, 10.1186/s13062-015-0035-z Pott, 2017, Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC, Oncotarget, 8, 11950, 10.18632/oncotarget.14447 Potter, H., Transfection by electroporation. Curr Protoc Mol Biol, 2003. Chapter 9: p. Unit 9.3. Rahman, 2017, CRISPRpred: A flexible and efficient tool for sgRNAs on-target activity prediction in CRISPR/Cas9 systems, PLoS One, 12, e0181943, 10.1371/journal.pone.0181943 Ramboer, 2015, Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes, Methods Mol Biol, 1250, 53, 10.1007/978-1-4939-2074-7_4 Rebouissou, 2017, Note of caution: Contaminations of hepatocellular cell lines, J Hepatol, 67, 896, 10.1016/j.jhep.2017.08.002 Rebouissou, 2020, Advances in molecular classification and precision oncology in hepatocellular carcinoma, J Hepatol, 72, 215, 10.1016/j.jhep.2019.08.017 Reel, 2021, Using machine learning approaches for multi-omics data analysis: A review, Biotechnol Adv, 49, 10.1016/j.biotechadv.2021.107739 Rees, 2018, Base editing: precision chemistry on the genome and transcriptome of living cells, Nat Rev Genet, 19, 770, 10.1038/s41576-018-0059-1 Ren, 2015, A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus, Scientific Reports, 5, 8865, 10.1038/srep08865 Ren, 2017, Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition, Clin Cancer Res, 23, 2255, 10.1158/1078-0432.CCR-16-1300 Ren, 2019, Efficiency Optimization of CRISPR/Cas9-Mediated Targeted Mutagenesis in Grape, Front Plant Sci, 10, 612, 10.3389/fpls.2019.00612 Replogle, 2020, Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing, Nature Biotechnology, 38, 954, 10.1038/s41587-020-0470-y Rimini, 2021, Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study, Hepatology Research, 51, 1229, 10.1111/hepr.13718 Rukhsar, 2022, Analyzing RNA-Seq Gene Expression Data Using Deep Learning Approaches for Cancer Classification, Applied Sciences, 12, 1850, 10.3390/app12041850 Rupp, 2017, CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells, Sci Rep, 7, 737, 10.1038/s41598-017-00462-8 Rushworth, 2020, In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer, Life Sci Alliance, 3, 10.26508/lsa.202000770 Sagnelli, 2020, Epidemiological and etiological variations in hepatocellular carcinoma, Infection, 48, 7, 10.1007/s15010-019-01345-y Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat Methods, 11, 783, 10.1038/nmeth.3047 Sanson, 2018, Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities, Nature Communications, 9, 5416, 10.1038/s41467-018-07901-8 Scheiter, 2022, RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues, Mol Oncol, 16, 1091, 10.1002/1878-0261.13135 Schubert, 2022, Genome-wide base editor screen identifies regulators of protein abundance in yeast, eLife, 11, e79525, 10.7554/eLife.79525 Shalem, 2014, Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 343, 84, 10.1126/science.1247005 Shao, 2020, Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma, Biomaterials Science, 8, 6579, 10.1039/D0BM00794C Sharma, 2021, Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?, J Clin Exp Hepatol, 11, 484, 10.1016/j.jceh.2020.12.006 Shearn, 2015 Shifrut, 2018, Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function, Cell, 175, 1958, 10.1016/j.cell.2018.10.024 Shigeta, 2020, Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma, Hepatology, 71, 1247, 10.1002/hep.30889 Shlomai, 2018, Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis, PLoS One, 13, e0207132, 10.1371/journal.pone.0207132 Si, 2020, Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening, Faseb j, 34, 13776, 10.1096/fj.202001067R Song, 2017, Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice, Gastroenterology, 152, 1161, 10.1053/j.gastro.2016.12.002 Stemmer, 2015, CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool, PLoS One, 10, e0124633, 10.1371/journal.pone.0124633 Suemura, 2019, CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma, Cancers (Basel), 11, 10.3390/cancers11091362 Sun, 2015, Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing, Angew Chem Int Ed Engl, 54, 12029, 10.1002/anie.201506030 Sun, 2018, Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma, Lab Invest, 98, 734, 10.1038/s41374-018-0027-6 Suresh, 2020, Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease, Front Oncol, 10, 10.3389/fonc.2020.601710 Tan, 2022, DNA base editing in nuclear and organellar genomes, Trends in Genetics, 38, 1147, 10.1016/j.tig.2022.06.015 Tan, 2022, GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma, Journal of Advanced Research Tang, 2020, TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors. JCI, Insight, 5 Tao, 2021, Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications, Hepatology, 74, 741, 10.1002/hep.31730 Tao, 2022, CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption, Medical Oncology, 39, 202, 10.1007/s12032-022-01808-7 ten Hacken, 2020, High throughput single-cell detection of multiplex CRISPR-edited gene modifications, Genome Biology, 21, 266, 10.1186/s13059-020-02174-1 Thomsen, 2022, Application of CRISPR for In Vivo Mouse Cancer Studies, Cancers (Basel), 14, 10.3390/cancers14205014 To, 2021, ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis, JHEP Rep, 3 Trivedi, T.B., et al., Crispr2vec: Machine Learning Model Predicts Off-Target Cuts of CRISPR systems. bioRxiv, 2020: p. 2020.10.28.359885. Tsherniak, 2017, Defining a Cancer Dependency Map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 Tzelepis, 2016, A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia, Cell Rep, 17, 1193, 10.1016/j.celrep.2016.09.079 Valiante, 2023, Molecular and Genetic Mechanisms of Hepatocellular Carcinoma, 11 VanDusen, 2021, Massively parallel in vivo CRISPR screening identifies RNF20/40 as epigenetic regulators of cardiomyocyte maturation, Nature Communications, 12, 4442, 10.1038/s41467-021-24743-z Vora, 2016, Next stop for the CRISPR revolution: RNA-guided epigenetic regulators, Febs j, 283, 3181, 10.1111/febs.13768 Wan, 2020, Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy, J Control Release, 322, 236, 10.1016/j.jconrel.2020.03.015 Wang, 2014, Genetic Screens in Human Cells Using the CRISPR-Cas9 System, Science, 343, 80, 10.1126/science.1246981 Wang, 2015, Identification and characterization of essential genes in the human genome, Science, 350, 1096, 10.1126/science.aac7041 Wang, 2017, Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras, Cell, 168, 890, 10.1016/j.cell.2017.01.013 Wang, 2018, Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening, Sci Adv, 4, 10.1126/sciadv.aao5508 Wang, 2018, RNA-seq assistant: machine learning based methods to identify more transcriptional regulated genes, BMC Genomics, 19, 546, 10.1186/s12864-018-4932-2 Wang, 2018, Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage, Cell Physiol Biochem, 50, 2017, 10.1159/000495048 Wang, 2019, Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth, Faseb j, 33, 8759, 10.1096/fj.201802213RR Wang, 2020, CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma, Gut, 69, 727, 10.1136/gutjnl-2019-318506 Wang, 2020, CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade, Cancer Discov, 10, 1912, 10.1158/2159-8290.CD-19-1448 Wang, 2021, CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies, Cancer Discov, 11, 1192, 10.1158/2159-8290.CD-20-1243 Wang, 2021, Exploring liver cancer biology through functional genetic screens, Nature Reviews Gastroenterology & Hepatology, 18, 690, 10.1038/s41575-021-00465-x Wang, 2022, The application of genome-wide CRISPR-Cas9 screens to dissect the molecular mechanisms of toxins, Comput Struct Biotechnol J, 20, 5076, 10.1016/j.csbj.2022.09.012 Wang, 2022, Structural biology of CRISPR–Cas immunity and genome editing enzymes, Nature Reviews Microbiology, 20, 641, 10.1038/s41579-022-00739-4 Weber, 2015, CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice, Proc Natl Acad Sci U S A, 112, 13982, 10.1073/pnas.1512392112 Wei, 2019, Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC, Nat Commun, 10, 4681, 10.1038/s41467-019-12606-7 Wei, 2020, Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing, Nature Communications, 11, 3232, 10.1038/s41467-020-17029-3 Westermann, 2021, Nobel Prize 2020 in Chemistry honors CRISPR: a tool for rewriting the code of life, Pflugers Arch, 473, 1, 10.1007/s00424-020-02497-9 Wollebo, 2013, Lentiviral transduction of neuronal cells, Methods Mol Biol, 1078, 141, 10.1007/978-1-62703-640-5_12 Woller, 2021, Prospects and Challenges for T Cell-Based Therapies of HCC, Cells, 10, 10.3390/cells10071651 Wong, 2015, WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system, Genome Biol, 16, 218, 10.1186/s13059-015-0784-0 Wu, 2015, Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells, Cell Res, 25, 67, 10.1038/cr.2014.160 Wu, 2019, Highly efficient therapeutic gene editing of human hematopoietic stem cells, Nat Med, 25, 776, 10.1038/s41591-019-0401-y Wu, 2020, Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment, J Exp Clin Cancer Res, 39, 97, 10.1186/s13046-020-01603-0 Xiang, 2021, Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning, Nature Communications, 12, 3238, 10.1038/s41467-021-23576-0 Xiao, 2021, Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription, J Clin Transl Hepatol, 9, 528 Xie, 2016, Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome, Cell Res, 26, 1099, 10.1038/cr.2016.101 Xie, 2017, Multiplexed Engineering and Analysis of Combinatorial Enhancer Activity in Single Cells, Mol Cell, 66, 285, 10.1016/j.molcel.2017.03.007 Xu, 2015, Sequence determinants of improved CRISPR sgRNA design, Genome Res, 25, 1147, 10.1101/gr.191452.115 Xu, 2020, CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity, Int J Biol Sci, 16, 2283, 10.7150/ijbs.33481 Xu, 2021, Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma, Cell Death Dis, 12, 920, 10.1038/s41419-021-04206-5 Xu, 2021, Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs, Nat Biotechnol, 39, 1403, 10.1038/s41587-021-00944-1 Xu, 2021, A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment, Cancer Res, 81, 6219, 10.1158/0008-5472.CAN-21-1017 Xue, 2014, CRISPR-mediated direct mutation of cancer genes in the mouse liver, Nature, 514, 380, 10.1038/nature13589 Yang, 2020, CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPAR&#x3b1; expression. Science, Advances, 6 Yang, 2021, Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology, Brief Bioinform, 22, 10.1093/bib/bbaa164 Yang, 2021, High-resolution characterization of gene function using single-cell CRISPR tiling screen, Nat Commun, 12, 4063, 10.1038/s41467-021-24324-0 Yang, 2021, WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signaling, Cancer Lett, 513, 50, 10.1016/j.canlet.2021.05.010 Yau, 2017, Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers, Cancer Res, 77, 6330, 10.1158/0008-5472.CAN-17-2043 Ye, 2019, The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma, Cell Death Discov, 5, 86, 10.1038/s41420-019-0165-7 Yedier-Bayram, O., et al., EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. bioRxiv, 2021: p. 2021.05.14.444239. Yen, 2021, Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West, PLoS One, 16, e0244939, 10.1371/journal.pone.0244939 Yin, 2021, Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma, ACS Cent Sci, 7, 2049, 10.1021/acscentsci.1c01143 Yu, 2017, CRISPR/Cas9-induced Targeted Mutagenesis and Gene Replacement to Generate Long-shelf Life Tomato Lines, Scientific Reports, 7, 11874, 10.1038/s41598-017-12262-1 Yu, 2018, Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection, Hum Gene Ther, 29, 51, 10.1089/hum.2017.032 Yu, 2022, Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer, Oncogene, 41, 191, 10.1038/s41388-021-02077-w Yu, 2022, Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells, ACS Chem Biol, 17, 918, 10.1021/acschembio.2c00006 Yuzugullu, 2009, Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells, Molecular Cancer, 8, 90, 10.1186/1476-4598-8-90 Zhang, 2017, Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases, Genome Biology, 18, 191, 10.1186/s13059-017-1325-9 Zhang, 2017, CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells, Front Med, 11, 554, 10.1007/s11684-017-0543-6 Zhang, 2021, The potential prognostic values of the ADAMTS-like protein family: an integrative pan-cancer analysis, Annals of Translational Medicine, 9, 1562, 10.21037/atm-21-4946 Zhang, 2022, NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN, J Transl Med, 20, 325, 10.1186/s12967-022-03519-z Zhang, 2022, Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis, J Exp Clin Cancer Res, 41, 24, 10.1186/s13046-022-02242-3 Zhang, 2022, Recent advances in systemic therapy for hepatocellular carcinoma, Biomarker Research, 10, 3, 10.1186/s40364-021-00350-4 Zhao, 2021, Review of applications of CRISPR-Cas9 gene-editing technology in cancer research, Biol Proced Online, 23, 14, 10.1186/s12575-021-00151-x Zhao, 2022, Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7–H3 in tumor cells, Journal for ImmunoTherapy of Cancer, 10, e004875, 10.1136/jitc-2022-004875 Zhen, 2014, In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9, Biochem Biophys Res Commun, 450, 1422, 10.1016/j.bbrc.2014.07.014 Zheng, 2019, CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma, Oncotarget, 10, 7058, 10.18632/oncotarget.27361 Zheng, 2019, Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma, J Cancer, 10, 5862, 10.7150/jca.31599 Zhong, 2021, Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects. Frontiers, Oncology, 11 Zhou, 2017, Tissue-specific DNA methylation is conserved across human, mouse, and rat, and driven by primary sequence conservation, BMC Genomics, 18, 724, 10.1186/s12864-017-4115-6 Zhou, 2018, Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection, Cancer Medicine, 7, 3031, 10.1002/cam4.1591 Zhou, 2020, Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively, J Cancer Res Clin Oncol, 146, 1509, 10.1007/s00432-020-03207-9 Zhu, 2016, Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library, Nat Biotechnol, 34, 1279, 10.1038/nbt.3715 Zhu, 2019, Guide RNAs with embedded barcodes boost CRISPR-pooled screens, Genome Biol, 20, 20, 10.1186/s13059-019-1628-0 Zhu, 2019, Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease, Cell, 177, 608, 10.1016/j.cell.2019.03.026 Zhu, 2021, AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma, Signal Transduct Target Ther, 6, 299, 10.1038/s41392-021-00713-1 Zhuang, 2017, Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cells, Oncotarget, 8, 77915, 10.18632/oncotarget.20946 Zou, 2022, N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer, Nat Commun, 13, 2672, 10.1038/s41467-022-30217-7